Oncology
Latest News
Do New Blood Tests for Cancer Meet the Right Standards?
These tests have not met the strict criteria typically required for traditional cancer screening tests.
Latest News
Diagnosing, Treating Rashes In Patients on Immune Checkpoint Inhibitors
Cutaneous immune-related adverse events are the most frequently reported and most visible adverse effects of checkpoint inhibition.
Feature
Clinical Controversy: Watch-and-Wait or Surgery in Rectal Cancer Near Complete Responders?
Watch-and-wait for near-complete clinical responders is “very controversial.”
From the Journals
Few Severe Toxicities After SBRT in Oligometastatic Cancer
SBRT, an alternative to chemotherapy and immunotherapy, offers treatment with a low rate (0.5%) of severe acute toxicities.
Latest News
Experts Highlight Challenges That Remain for AI Devices in Triaging Skin Cancer
Before AI makes significant inroads in dermatology, clinicians need to see more verifiable data, according to dermatologist Dr. R...
Feature
BRCA Mutations in Men: Important but Often Overlooked
Most are unaware of the associated cancer risks, and management recommendations for male BRCA carriers.
From the Journals
FIT Screening Cuts Colorectal Cancer Mortality by One Third
Researchers used data from two health systems with long-standing programs of mailing FITs to compare 1103 cases of adults who had died of CRC with...
From the Journals
Colorectal Cancer: New Primary Care Method Predicts Onset Within Next 2 Years
Researchers conducted a retrospective cohort study of 50,387 UK Biobank participants reporting a CRC symptom in primary care at age 40 years or...
From the Journals
Rheumatoid Arthritis May Raise Lung Cancer Risk, Particularly in Those With ILD
Rheumatoid arthritis increased the risk for lung cancer, and this risk was threefold higher in patients with rheumatoid arthritis–associated...
Latest News
Nonmelanoma Skin Cancer: Encouraging Data on Laser Treatment
Data was strongest for the use of lasers for treating basal cell carcinoma, especially pulsed-dye lasers.
From the Journals
Immunotherapy and Survival in Advanced NSCLC: Does Obesity Matter?
Researchers evaluated 31,257 patients with advanced NSCLC from Japan who received immune checkpoint inhibitors or conventional chemotherapy.